no re thin drone

Upload: papaindo

Post on 06-Jul-2018

215 views

Category:

Documents


0 download

TRANSCRIPT

  • 8/17/2019 No Re Thin Drone

    1/9

    SAMPLE

    Matrix:  blood

    Sample preparat ion:

      Condition  a  Bond-Elut  C18 SPE cartridge with M eOH and water.

    Add

      500 |xL

     plasma

     to the SPE

      cartridge, wash with

      2 mL

     water, wa sh with

      2 mL

    MeO H: water 20:80 , elute w ith

     two 500

     |JLL aliquots

     of

      MeOH. Evaporate

      the

     eluate

     to

    dryness under a stream of nitrogen, reconstitute the residue in 50 |xL MeOH : water 20:

    80,

     inject a 20  JULL aliquot.

    HPLCVARIABLES

    Column:

      100 X 1 5 |xm Hyp ersil ODS

    Mobile phase:

      MeCN : MeO H: water 25:25 :50

    Flow rate:  0.1

    Inject ion vo lum e:

     20

    Detector: UV

    CHROMATOGRAM

    Retent ion t ime:

     20

    Limit of detect ion:

      2

     ng/mL

    OTHER SUBSTANCES

    Extracted:

      androstenedione, 20a-hydroxy-4-pregnen-3-one, 17a-hydroxyprogesterone, pro-

    gesterone, testosterone

    KEYWORDS

    microbore; rat; plasma; SPE

    REFERENCE

    Taylor,

     R.B.;

     Kendle,

     K.E.;

     Reid,

     R.G.;

     Hung,

     CT.

     Chromatography

     of

     progesterone

     and its

     major

     me-

    tabolites

     in rat

      plasma using microbore high-performance liquid chromatography columns with

     con-

    ventional injection

      and

     detection systems. J.Chromatogr.,

     1987, 385,

     383—392

    SAMPLE

    Matrix:

      blood

    Sample preparat ion:

      2 mL

     Plasma

      5 mL

     hexan e: dichloromethane

     1:1,

     shake

     for 10 min,

    centrifuge  at 2000 rpm for 10 min. Remove 4 mL of the organic phas e and evaporate it at

    55° under nitrogen. Reconstitute residue in 300 |xL mobile p has e, inject a 150 |xL aliquot.

    HPLCVARIABLES

    Column:

      250 X 4.6 5 |xm

     L iChrosorb

     RP-8

    Mobile phase:

      MeO H: MeCN : water 20:30 :50

    Flow rate:  2

    Inject ion volume:

     150

    Detector:

      UV 254

    CHROMATOGRAM

    Retent ion t ime:  8

    Limit

     of

     qu ant i ta t ion:

      2

     ng/mL

    Norethindrone

    Molecular formu la: G

    20

    H

    26

    O

    2

    Molecular weight:

      298.4

    CAS Registry No :

      68-22 -4, 51-98-9 acetate)

  • 8/17/2019 No Re Thin Drone

    2/9

    KEYWORDS

    plasma

    REFERENCE

    Loo,

     J.C.K.;

     Brien,

     R.

     Analysis

     of

     norethindrone

     in

     plasma

     by

     high-performance liquid chromatography.

    J.Liq.Chromatogr. 1981

    4

    871-877

    SAMPLE

    Matrix: bulk

    HPLCVARIABLES

    Column:

      250 X 4 10 jxin LiChrosorb RP-18

    Mobile phase: MeOH: water 70:30

    Flow rate: 1

    Injection volume: 25

    Detector:  UV 240

    CHROMATOGRAM

    Retent ion t ime:  7

    OTHER SUBSTANCES

    Simultaneous:

      ethinyl estradiol, impurities, norgestrel

    REFERENCE

    Gdrdg, S.; Herenyi, B. Analysis of stero ids . XXXVIIL The use of high-performance liquid chrom atography

    with diode-array

     UV

     detection

     for

     estimating impurity profiles

     of

     steroid d rugs. J.Chromatogr.

    1987

    400

    177-186

    SAMPLE

    Matrix:  food

    Sample preparation:

      Dissolve apple extracts in THF, inject a 10 |xL extract.

    HPLCVARIABLES

    Column:

      300 X 3.9 jxBondapak C18

    Mobile phase: MeOH: THF: water 11:26:63

    Flow rate: 1.7

    Injection volume: 10

    Detector: UV

     254

    CHROMATOGRAM

    Retention time: 11.6

    OTHER SUBSTANCES

    Simultaneous:

      degradation products, impurities

    KEYWORDS

    apples; fruit; stability-indicating

    REFERENCE

    Mayberry, D.O.; Kow blansky, M.; L ane, RA.; Wray, RE. Determination of norethindrone stability on Red

    Delicious apples. J.Pharm.ScL

    1990

    79 746-749

    SAMPLE

    Matrix:  formulations

  • 8/17/2019 No Re Thin Drone

    3/9

    Sample p re par at io n : Dissolve 12 tablets in 600 mL water with stirring at 75 rpm, remove

    3 mL sample, centrifuge at 3000 rpm for 15 min, inject a 250 |xL aliquot.

    HPLCVARIABLES

    Colu mn: 100 X 4.6 3 jxm Phenomenex IB-SiI 3 C18

    Mobile p ha se : MeCN: water 40:60, pH 5.6

    Flow rate: 1.2

    Injection volume: 250

    D etec tor: UV 200

    C H R O M A T O G R A M

    Retention time: 7.7

    OTHER SUBSTANCES

    Simultaneous: ethinyl estradiol

    KEYWORDS

    tablets; modification of USP method

    REFERENCE

    Dorantes, A.; Stavchansky, S. Modification of the U.S.P. dissolution method for the analysis of noreth-

    indrone and ethinyl estradiol tablets. J.Pharm.ScL 1994, 83 3 7 9 - 3 8 1

    SAMPLE

    Matrix: formulations

    Sam ple p re pa ra tion : Dissolve 6 tablets in 600 mL water: isopropanol 97:3, remove 5 mL

    samples, centrifuge at 1500 rpm for 10 min, inject a 50-200 |xL aliquot.

    HPLCVARIABLES

    Column: 300 X 3.9 10 jxm Bondapak C18

    M obile ph as e: MeCN: water 55:45

    Flow rate: 1

    Injection volume: 50-200

    Detec tor: UV 200

    OTHER SUBSTANCES

    Simultaneous: mestranol

    KEYWORDS

    tablets; modified USP method

    REFERENCE

    Nguyen, H.T.; Shiu, G.K.; Worsley, W.N.; Skelly, J.R Dissolution testing of norethindrone: ethinyl estra-

    diol, n orethindrone : mestranol, and norethindrone ace tate: ethinyl estradiol combination tablets.

    J.Pharm.ScL 1990 79 163-167

    SAMPLE

    Matrix: formulations

    Sa m ple p re para ti on : Dissolve 6 tablets in 600 mL 100 mM HCl containing 0.02 sodium

    lauryl sulfate, remove 5 mL samples, centrifuge at 1500 rpm for 10 min, inject a 50-200

    IxL aliquot.

    HPLCVARIABLES

    Colu mn: 220 X 4.6 5 |jim Spheri-5 C18

    Mobile p has e: MeCN: 20 mM pH 6.0 phosphate buffer 35:65

  • 8/17/2019 No Re Thin Drone

    4/9

  • 8/17/2019 No Re Thin Drone

    5/9

    Inject ion vo lum e:

      10

    Detector:

      U V 240

    CHROMATOGRAM

    Retent ion t ime:

      4.6 (norethindrone), 8.6 (norethindrone acetone)

    Limit of detect ion:  5 jig/mL

    OTHER SUBSTANCES

    Simul taneous:

      asp irin, benzyl alcohol, benzyl ben zoate, caffeine, calu stero ne, cortisone, de-

    hydroepiandrosterone (UV 210), formebolone, mesterolone (UV 210), methandriol (UV

    210), m ethandrostenolone, m ethenolone acetate, methyltestosterone, m ibolerone, nandro-

    lone, nandrolone acetate, nandrolone propionate, norethandrolone, norgestrel, oxymeth-

    olone, stanozolol, testolactone, testostero ne, testostero ne a cetate, testos terone propion ate,

    trenbolone acetate

    Interfering:

      boldenone, ethisterone, fluoxymesterone, oxandrolone (UV 210)

    KEYWORDS

    oils;

      tablets; suspensions

    REFERENCE

    Walters, M.J.; Ayers, R.J.; Brown, D.J. Analysis of illegally distributed anabolic steroid products by

    liquid chromatography with identity confirmation by mass spectrometry or infrared spectrophotom-

    etry  J.Assoc.Off.Anal.Chem. 1990 73 904-926

    SAMPLE

    Matrix:

      formulations

    Sample preparat ion:

      Dissolve 5 g cream con taining 0.00925 fluocinonide, 0.00365 pro-

    cinonide, and 0.0021 ciprocinonide in 2.5 mL THF, add norethin dron e, dilute to 25 mL

    with MeOH, centrifuge, inject a 25  JULL aliquot onto column A with mobile ph ase A and

    allow com ponents to elu te from column A to column B for 7 m in. After 7 m in rem ove

    column A from circuit, mo nitor effluent from column B . Back-flush column A w ith m obile

    pha se B for 5 min, equ ilibrate column A with mobile ph ase A for 5 min before next

    injection.

    HPLCVARIABLES

    Column:  A 30 X 4.6 5 >jim Spheri-5 ODS (B rownlee); B 70 X 2.1 Wh atm an Co :Pell ODS +

    250 X 4.6 5 |jim U ltras ph ere C18

    Mobile phase:  A M eCN :THF:water 4 3:4 :53 ; B MeOH :THF 75:25

    Flow rate: A 1.5; B 1

    Inject ion volume:

      25

    Detector:

      UV 260 for 22 min then UV 236

    CHROMATOGRAM

    Retent ion t ime: 12

    Internal s tandard:  norethindrone

    OTHER SUBSTANCES

    Simul taneous:  ciprocinonide, fluocinolone acetonide, fluocinonide, procinonide

    KEYWORDS

    creams; column-switching; norethindrone is IS

    REFERENCE

    Conley, D.L.; Benjamin, E.J. Automated high-performance liquid chromatographic column switching

    techniqu e for the on-line clean-up and analy sis of drugs in topical cream formulations.  J.Chromatogr.

    1983, 257 337-344

  • 8/17/2019 No Re Thin Drone

    6/9

    SAMPLE

    Matrix:  formulations

    Sample preparat ion:

      1 Tablet + 4 mL 50 mM KH

    2

    PO

    4

    , rotate 15 min, add 2 mL 1 ixg/mL

    o-phenylphenol in mobile pha se, add 4 mL MeOH , rot ate 15 min , centrifuge. Remove

    supernatant, extract residue twice with 5 mL mobile phase (10 min rotation), combine

    supernatants, inject 50

      |JLL

      aliquot.

    HPLC VARIABLES

    Column:  250 X 4.6 10 (xm L iChrosorb RP 8

    M obile pha se: MeOH:50 mM KH

    2

    PO

    4

      3:2

    Flow rate: 2

    Inject ion volum e: 50

    De tecto r: UV 220

    CHROMATOGRAM

    Retent ion t ime:

      9 (norethindrone), 19.3 (norethindrone acetate)

    OTHER SUBSTANCES

    Simul taneous:

      methyltestosterone, norgestrel

    Interfering:  ethinyl estradiol

    KEYWORDS

    tablets; stability-indicating

    REFERENCE

    Strus iak, S.H.; Hoogerheide, J.G.; G ardner, M.S. Determ ination of ethinyl estrad iol in solid dosage forms

    by high-performance liquid chromatography.

      J.Pharm.Sci.

    1982

    71

    636-640

    SAMPLE

    Matrix:

      reaction mixtures

    Sample preparat ion:  If necessary, remove oxidizing power of solution by adding sodium

    metabisulfite, inject a 20

      JJLL

     aliquot.

    HPLC VARIABLES

    Guard column:  15 X 4.6 5 |xm M icrosorb C8

    Column:

      250 X 4.6 5 |xm Microsorb C8

    Mobile phase:

      M eCN: 100 mM KH

    2

    PO

    4

      adjusted to pH 7 with 1 M KOH 50:5 0

    Flow rate: 1

    Inject ion volume: 20

    Detector: UV

     254

    CHROMATOGRAM

    Retent ion t ime: 8 .7

    Limit of detect ion:  100 ng/mL

    REFERENCE

    L unn , G.; Rhodes, S.W.; Sanso ne, E.B.; Schmuff,  N.R. Photolytic destruction and polymeric resin decon-

    tamination of aqueous solutions of pharmaceuticals.

      J.Pharm.Sci.

    1994

    83

    1289-1293

    SAMPLE

    Matrix:

      solutions

    HPLCVARIABLES

    Column:  50 X 4.6 5 Jim Supelcosil L C-18

    Mobile phase:

      MeOH : TH F: water 10:20:70

  • 8/17/2019 No Re Thin Drone

    7/9

    Flow rate: 2

    Inject ion volume: 20

    Detector: UV 220

    CHROMATOGRAM

    Retent ion t ime:  3 (norethindrone), 7.4 (norethindrone acetate)

    OTHER SUBSTANCES

    Simul taneous:  ethinyl estradiol, norethynodrel acetate, norgestrel

    REFERENCE

    Supelco Catalog Supelco Inc Bellefonte PA

    1996, p. A130

    SAMPLE

    Matrix:

      solutions

    Sample preparat ion:  Inject a 5  JJLL aliquo t of a 10 jxg/mL solution in M eOH.

    HPLCVARIABLES

    Column:  75 X 4.6 3 fxm U ltras ph ere ODS

    Mobile phase:

      MeC N: 10 mM am mon ium acetate buffer 45:5 5

    Flow rate: 0 .5

    Inject ion volume: 5

    Detector: UV 254

    CHROMATOGRAM

    Retent ion t ime:

      5.941

    OTHER SUBSTANCES

    Simul taneous:  boldenone, epime thand ienon e, ep itestosterone, fluoxymesterone, 6p-hy-

    droxymethandienone, methandienone, oxymetholone (UV 280), trenbolone

    REFERENCE

    Barron, D.; Pascual, J.A.; Segura, J.; Barbosa, J. Prediction of LC retention of steroids using solvato-

    chromic parameters.  Chromatographia 1995, 41 573-580

    SAMPLE

    Matrix:  solutions

    Sample preparat ion:

      Inject a 20

      \iL

      aliquot of a solution in MeO H: w ater 50:5 0.

    HPLCVARIABLES

    Column:

      250 X 4 7 |jim L ichroCAR T RP -8 (Merck)

    Mobile phase:

      MeCN: MeOH: water 32:37:31

    Flow rate: 1

    Inject ion vo lum e:

      20

    Detector: UV

     230

    CHROMATOGRAM

    Retent ion t ime: 5

    OTHER SUBSTANCES

    Simul taneous:  fluoxymesterone, m edrogestone, m estrano l, progesterone, tes tostero ne

    propionate

  • 8/17/2019 No Re Thin Drone

    8/9

    REFERENCE

    Gau, YS.; Sun, S.W.; Chem, R.R.-L. Optimization of high-performance liquid chromatographic separa-

    tion for progestogenic, estrogenic, and androgenic steroids usin g factorial design.  J.Liq.Chromatogr.

    1995,  18 2373-2382

    SAMPLE

    Matrix:  solutions

    HPLCVARIABLES

    Column:  250 X 4.6 10 ^m Nucleosil C18

    Mobile phase:  MeCN:THF-.water 12.9:22.4:64.7

    Flow rate: 1

    D etecto r: UV 240

    CHROMATOGRAM

    Retent ion t ime:

      8.5 (norethindrone), 15.5 (norethindrone acetate)

    OTHER SUBSTANCES

    Simul taneous:

      estrone, ethinyl estradiol, mestranol, norgestrel

    REFERENCE

    Gazdag, M.; Szepesi, G.; Szeleczki, E. Selection of high-performance liquid chromatographic methods in

    pharmaceutical analysis. I. Optimization for selectivity in reversed-phase chromatography.

    J.Chromatogr.

    1988

    454 8 3 - 9 4

    SAMPLE

    Matrix:  solutions

    HPLCVARIABLES

    Column:  250 X 4.6 5 ^m L iChrosorb Si 60

    Mobile phase:  Hex ane: dioxane: isopropanol 95 :3: 2

    Flow rate: 1

    Detector: UV 254

    CHROMATOGRAM

    Retent ion t ime:

      20 (norethindrone), 10 (norethindrone acetate)

    OTHER SUBSTANCES

    Simul taneous:  estrone, ethinyl estradiol, mestranol, norgestrel

    KEYWORDS

    normal phase

    REFERENCE

    Gazdag, M .; Szepesi, G.; Fabian-Varga, K. Selection of high-performance liquid chrom atographic m eth-

    ods in pharmaceutical analysis. II. Optimization for selectivity in normal-phase systems.

    J.Chromatogr.

    1988

    454 9 5 - 1 0 7

    SAMPLE

    Matrix:  solutions

    Sample preparat ion:  Dissolve in MeO H: w ate r 1:1 at a conc entration of 50 |xg/mL , inject

    a 10

      |JLL

      aliquot.

    HPLCVARIABLES

    Column:

      300

      X 3.9 10 |xm

      (xBondapak C18

  • 8/17/2019 No Re Thin Drone

    9/9

    Mobile phase:

      MeOH: acetic acid: triethylamine: water 60:1.5:0.5:38

    FIo

    5

    W rate: 1.5

    Injection volume: 10

    Detector: UV 240

    CHROMATOGRAM

    Retention time: 12

    OTHER SUBSTANCES

    Simultaneous:  hydrocortisone acetate, methyltestosterone, prednisolone, prednisolone suc-

    cinate, prednisone, progesterone

    REFERENCE

    Roos,

     R.W.;

     L au-Cam,

      CA.

     Gen eral reversed-ph ase high-performance liquid chromatograp hic method

    for

      the

      separation

      of

      drugs using triethylamine

      as a

      competing base.

      J.Chromatogr.

    1986

    370

    403-418

    •  • •

    ANNOTATED BIBLIOGRAPHY

    Tang, G.P.; Chen, Q.Q. [Column switching H PL C method for determination of in vivo relea se of noreth-

    indrone-alpha , beta-poly (3-hydroxypropyl)-DL -asparamide conjugate].

     Y ao Hsueh Hsueh Pao

    1994

    29 301-305

    Lee, G.J.-L.; Oyang, M.-H.; Bautista,

      J.;

      Kushinsky,

      S.

      Determination

      of

     ethinylestradiol

      and

     noreth-

    indrone

     in a

      single specimen

     of

     plasma

     by

     autom ated high-performance liquid chromatograp hy

     and

    subsequent radioimmunoassay.

      J.Liq.Chromatogr.

    1987 10 2305-2318 [LOD 20-50 pg/mL ]

    Papas,

     A.N.;

     Marchese,

     S.M.;

     Delaney,

     M.F.

     Rapid determina tion

     of

     norethindrone

     and

     ethinylestradiol

    in oral contraceptive tablets

     by

      reversed-phase liquid chromatography.

     LC

     Mag.

    1985

    3

    354-358

    [tablets; column temp

     25;

     simultaneous ethinylestradiol; Chem.Abs.,

     102,

     226114]

    Swynnerton,  N.R; Fischer, J.B. Determination  of ethyny lestradiol  and norethindrone  in synthetic in-

    testinal fluid

      and in

      timed-release oral formulations.

      J.Liq.Chromatogr.

    1980

    3

    1195-1204

     [for-

    mulations; also ethinylestradiol]

    Next page

    http://81765_13c.pdf/http://81765_13c.pdf/